Tanja is a Managing Director at Angelini Ventures. Prior to joining Angelini Ventures, Tanja was  the CEO of Debiopharm Innovation Fund in Lausanne, Switzerland, where she built a portfolio of 17 digital health and data driven R&D tech companies, and consolidated a legacy portfolio of diagnostics investments. 

Before her career in start-up investments, Tanja was the Managing Partner of Innomedica Ltd, a boutique strategy and transaction consulting company in life sciences, and a founder-CEO of a market research agency BioSolutions INT.

During her career, Tanja has worked with over 90 healthtech companies globally, leading to broad experience in innovative product development, commercial strategies, and building winning teams. Tanja is an experienced board member and chairwoman with a track record of successful M&A exits.

She holds an MSc in Applied Microbiology and Biochemistry from Helsinki University of Technology (nowadays Aalto University).